Navigation Links
Varian Medical Systems Announces X-Ray Products Contract With Toshiba Medical Systems
Date:1/27/2011

SALT LAKE CITY, Jan. 27, 2011 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced the execution of a three year, approximately $450 million contract for Varian to supply medical imaging subcomponents to Toshiba Medical Systems for integration into diagnostic imaging equipment for the global market. Orders will be booked over the period of the agreement.

"We are very proud to announce this contract as it marks the latest chapter in our 30+ year relationship with Toshiba Medical Systems," said Robert Kluge, corporate senior vice president at Varian. "Over the years, our two companies have developed a close cooperation at all levels of the business. We have complementary design engineering and manufacturing capabilities, and work together well to realize new products and improve existing ones."

About Varian Medical Systems

Varian X-Ray Products is a premier supplier of X-ray tubes and digital detectors for X-ray imaging in medical, dental, veterinary, scientific, and industrial applications.  X-Ray Products is a business unit of Varian Medical Systems, Inc., of Palo Alto, California.  Varian is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy.  The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices.  The company also supplies X-ray imaging products for cargo screening and industrial non-destructive inspection.  Varian Medical Systems employs approximately 5,300 people who are located at manufacturing sites in North America, China and Europe and in its 70 sales and support offices around the world. For more information, visit http://www.varian.com/.

About Toshiba Medical Sys
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2011
2. Varian Medical Systems Schedules First Quarter FY2011 News Release and Conference Call
3. EGEN, Inc. Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment
4. For the Treatment of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin as the Standard Second-Line Treatment for Platinum Sensitive Patients
5. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
6. Varian Medical Systems to Display Medical X-Ray Tubes and PaxScan® Digital X-Ray Image Detectors at MEDICA 2010 International Trade Fair
7. D3 Radiation Oncology Solutions has Completed Collaborative Commissioning of Two Varian TrueBeam Medical Linear Accelerators at the John Theurer Cancer Center, Hackensack University Medical Center
8. Varian Medical Systems Management to Present at Lazard Capital Markets 7th Annual Healthcare Conference
9. Saudi Arabias King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy
10. Varian Medical Systems to Supply Four Advanced Radiotherapy Treatment Machines to Global Hospitals in India
11. CURE Foundation Selects Varian Medical Systems to Supply Radiotherapy Technology for Five New Cancer Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... Executive Officer of Neurocrine Biosciences, will be presenting at the ... in Boston.   The live presentation takes place ... 8:20 a.m. Pacific Time.  The presentation will be webcast and ... . If you are unable to attend ...
(Date:5/23/2013)... Hearing health affects a man,s lifestyle, and if ... and professionally engaged, he should address any hearing loss he ... Better Hearing Institute (BHI) is delivering to men ... Week , which leads up to and includes Father,s Day. ... through June 16. To help men address ...
(Date:5/23/2013)... 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: ... based on intellectual property developed and owned by ... foremost medical research center, today announced that its ... funding from the Israeli Ministry of Industry and ... support product development and advance clinical trials. Cell ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... Mich., Aug. 6 Terumo Heart, Inc. announced,that ... Ventricular Assist,System (LVAS) took place on July 30 ... Arbor, Michigan. The surgery was performed by,Francis Pagani, ... Pivotal Trial. DuraHeart is the world,s first third,generation ...
... Nexgen Spine, a leading,developer of innovative spinal implants ... today that it has received CE mark,approval to ... European,Union., "We are delighted that the Physio-L(R) ... Alastair Clemow, Ph.D., President and CEO,of Nexgen Spine. ...
Cached Medicine Technology:First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial 2Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc 2
(Date:5/23/2013)... Science published an article about bexarotene as ... important starting point for further Alzheimer,s research. The research ... VIB and KU Leuven in collaboration with the ... scientists at Janssen Pharmaceutica, Beerse, also tested this candidate ... were different, as were those of two American study ...
(Date:5/23/2013)... while being dragged to its destruction inside a ... sending signals that thwart the development of tumor-suppressing ... an early online publication at Nature . ... by tumors, the epidermal growth factor receptor (EGFR) ... team led by scientists at The University of ...
(Date:5/23/2013)... May 23, 2013 The Rottenstein Law ... firm, has created the Tylenol Lawsuit Information Center at ... Tylenol users and those who are considering filing lawsuits. ... to potentially cause severe liver damage, according to a ... In the “safety communication,” the FDA warned consumers ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... have a great deal of control over their level ... their weight, yet far fewer are actually taking that ... International Food Information Council (IFIC) Foundation’s 2013 Food & ... of respondents say it’s possible to have “a great ...
(Date:5/23/2013)... IL (PRWEB) May 23, 2013 Jeanne ... fifth anniversary of its popular and only free OCD ... a successful continuing resource for OCD sufferers, the group ... OCD, and related disorders. This allows group participants ... and Exposure and Response Prevention. , “Participants in Beyond ...
Breaking Medicine News(10 mins):Health News:New insights contradict promising Alzheimer's research 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 2Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 3Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 4Health News:Beyond OCD Support Group Marks Fifth Anniversary 2
... WASHINGTON Say nanotechnology, and geeks imagine iPhones, laptops ... of the 580 products in a newly updated ... items as tennis racquets, clothing, and health products. ... Nanotechnologies at www.nanotechproject.org/consumerproducts, the updated inventory includes Head ...
... Oct. 2 On Saturday, September 29, over 850,people ... of the most,grueling workouts ever devised, the Crossfit Fight ... Cure, an initiative of the Prostate Cancer,Foundation. Over 4,000 ... pledges and thanks to a matching funds grant from ...
... Ranbaxy One of Few Companies to Offer Both Suspension ... Ranbaxy Pharmaceuticals Inc.,(RPI), a wholly owned subsidiary of Ranbaxy ... approval from the U.S. Food and,Drug Administration (U.S. FDA) ... mg/5 mL and 250 mg/5 mL. Ranbaxy is the ...
... CYNACON/OCuSOFT (OCuSOFT,Inc.), a company specializing in ... optometrists, is pleased to announce the,appointment of ... Scientific,Advisory Board. *(LOGO: Send2Press.com/mediaboom/07-0803-Occusoft_72dpi.jpg) Dr. ... Eye Surgery in New York,City. She is ...
... producers,in the United States should be cautious but not ... director at Kansas,State University. Gary Anderson, director of ... the virus, which recently cropped up in the United,Kingdom, ... United States. "We are fortunate that bluetongue virus ...
... SAN FRANCISCO, Oct. 2 The American Dental,Association ... the,disposal of dental amalgam waste to include the ... plumbing to capture and,remove at least 95 percent ... system. The use of separators will allow greater ...
Cached Medicine News:Health News:Nanotechnology: not just for geeks 2Health News:Crossfit Workout Challenge Raises Over $500,000 in Four Hours for Athletes for a Cure 2Health News:Ranbaxy First to Gain Approval to Manufacture and Market Clarithromycin for Oral Suspension, USP 2Health News:K-State Veterinary Lab Routinely Tests For Bluetongue Virus; Lab Director Says Strains Found in Kansas, U.S. Usually Less-Virulent 2Health News:ADA Updates Environmental Recommendations for Handling Waste 2
... any arm -- simply bend the aluminum forearm ... The cuffs are connected by an aluminum bar ... elbow angle. The central part of the joiner ... elbow joint.,Special attention is paid to the patient ...
... lightweight ankle splint may be used for ... ankle. It is effective in stabilizing ... or after cast removal. The rigid ... excellent side-to-side support. The stays also ...
... is designed to assist ambulation for those ... resulting in drop-foot. The anatomically correct shape ... is fabricated from specially formed orthopedic grade ... and reliability. For a more comfortable individual ...
... The VacoSplint has a rigid shell with ... an immobilized foot/ankle. The VacoSplint is a non-weight ... weight bear he/she should transfer to the STORM ... remove the nylon liner from the STORM and ...
Medicine Products: